Advertisement
Anesthesiology and Pulmonary Medicine
Subscribe to Anesthesiology and Pulmonary Medicine
View Sample

FREE Email Newsletter

Radiation exposure poses similar risk of first and second cancers in atomic bomb survivors

September 14, 2010 9:34 pm | by EurekAlert | News | Comments

(Fred Hutchinson Cancer Research Center) The first large-scale study of the relationship between radiation dose and risk of multiple cancers among atomic bomb survivors in Hiroshima and Nagasaki, Japan, reveals a similar risk in the development of first and second subsequent cancers.

Reportlinker Adds Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016

September 14, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

NEW YORK, Sept. 14 /- Reportlinker.com announces that a new market research report is available in its catalogue: Respiratory Devices - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016...

Palmetto Health Richland Hospital Becomes First in South Carolina to Noninvasively, Wirelessly Monitor Patients Using State-of-the-Art Masimo Patient SafetyNet™ System

September 14, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 14 /- Palmetto Health Richland in Columbia—South Carolina's largest and most comprehensive healthcare resource, and Masimo (Nasdaq: MASI ) today jointly announced South Carolina's first installation of Masimo Patient SafetyNet, an advanced remote monitoring and...

Advertisement

Clinical Experts Detail How They Use Varian's TrueBeam™ Technology to Improve the Precision and Speed of Cancer Treatments

September 14, 2010 7:35 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Sept. 14 /- Cancer treatment experts today reported their experiences with early treatments using the new TrueBeam system from Varian Medical Systems (NYSE: VAR ), aimed at increasing the speed and precision of radiotherapy and radiosurgery treatments. Clinicians from...

New task force report on bisphosphonate use and atypical femur fractures in osteoporosis patients

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Burness Communications) A widely prescribed class of drugs is highly effective in reducing common bone fractures in people with osteoporosis, but an expert panel announces that these same drugs -- when used long term -- may be related to unusual but serious fractures of the thigh bone.

Study identifies underlying dysfunction of seemingly non-critical heart condition

September 13, 2010 10:31 pm | by EurekAlert | News | Comments

(Nationwide Children's Hospital) Repairing small, seemingly benign holes in a child's heart may be more clinically important than previously thought, as dysfunction could be lurking out of sight. These are the findings from a study conducted by doctors and researchers at Nationwide...

Breakthrough in drug trial offers hope for heart attack patients

September 13, 2010 12:31 pm | by EurekAlert | News | Comments

(University of Sheffield) New findings from a major drug trial have brought experts a step closer to developing a drug which could prevent thousands of British deaths from heart attacks.

Zargis Signs Agreement to Provide Ontario Telemedicine Network With Remote Stethoscope Solution

September 10, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn., Sept. 10 /- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (OTCQB: SPDE), today announced that it has signed an agreement with the Ontario Telemedicine Network (OTN) providing for the delivery and testing of Zargis' award-winning telemedicine...

Advertisement

Varian Medical Systems Spotlights TrueBeam Treatment System for First Time in Europe at ESTRO 2010, September 12-16, Barcelona

September 10, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

BARCELONA, Spain, Sept. 10 /- Varian Medical Systems (NYSE: VAR ) is spotlighting its new TrueBeam™ medical linear accelerator for fast, powerful and efficient cancer treatments at the European Society for Therapeutic Radiology and Oncology exhibition in Barcelona next week. A...

Business & Decision North America Announces the Successful Go-Live of Microsoft Dynamics AX at DeVilbiss Healthcare

September 9, 2010 11:34 am | by Bio-Medicine.Org | News | Comments

WAYNE, Pa., Sept. 9 /- DeVilbiss Healthcare has selected Business & Decision, following a thorough selection process, to ensure the successful implementation of its Microsoft Dynamics AX solution. As part of the separation from Sunrise Medical, DeVilbiss sought to select and implement...

HealthSouth Declares Dividend on 6.5% Series A Convertible Perpetual Preferred Stock

September 9, 2010 11:33 am | by Bio-Medicine.Org | News | Comments

BIRMINGHAM, Ala., Sept. 9 /- HealthSouth Corporation (NYSE: HLS ) announced today that its board of directors has declared a regular quarterly dividend of $16.25 per share on its 6.5% Series A Convertible Perpetual Preferred Stock, payable on Oct. 15, 2010, to holders of record on Oct. 1,...

Dr. Robert Shorr, Leading Scientist in Cancer Metabolism, to Speak at Two Upcoming Pharmaceutical Conferences

September 9, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

CRANBURY, N.J., Sept. 9 /- Cornerstone Pharmaceuticals, Inc., the cancer metabolism company, today announced that its CEO, Robert Shorr, Ph.D., D.I.C., will be speaking and Co-Chairing The Center for Business Intelligence's (CBI's) 4th Annual Oncology Clinical Trials Summit and chairing a...

Use of medication for insomnia or anxiety increases mortality risk by 36 percent

September 9, 2010 12:31 am | by EurekAlert | News | Comments

(Université Laval) Taking medications to treat insomnia and anxiety increases mortality risk by 36 percent, according to a study conducted by Geneviève Belleville, a professor at Université Laval's School of Psychology. The details of this study are published in the latest edition of the...

Advertisement

Using chest compressions first just as successful as immediate defibrillation after cardiac arrest

September 8, 2010 9:34 pm | by EurekAlert | News | Comments

(University of Michigan Health System) In cardiac arrest, is it best to start pumping on the victim's chest or give an immediate shock to the heart? The University of Michigan learns both rescue strategies are effective, yet chest compressions before defibrillation may be best in events...

Masimo to Present at Stifel Nicolaus 2010 Healthcare Conference

September 8, 2010 1:34 pm | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Sept. 8 /- Masimo (Nasdaq: MASI ) today announced that its management is scheduled to present at the Stifel Nicolaus 2010 Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 15, at 8:00 a.m. ET.  A live audiocast of the presentation will...

BCM Human Genome Sequencing Center joins NIH's Pharmacogenomics Research Network

September 7, 2010 10:33 am | by Baylor College of Medicine | News | Comments

The Baylor College of Medicine Human Genome Sequencing Center has received a five-year, $2.3 million grant to join the National Institutes of Health's Pharmacogenomics Research Network , a collaborative project that seeks to advance research on how genes affect people's responses to a...

Study finds more Americans bypassing their personal physician when immediate treatment required

September 7, 2010 8:34 am | by EurekAlert | News | Comments

(Emory University) Only 45 percent of the 354 million annual visits for acute care in the United States are made to patients' personal physicians, as Americans increasingly make busy emergency departments, specialists or outpatient care departments their first point of contact for...

Researchers identify how bone-marrow stem cells hold their 'breath' in low-oxygen environments

September 2, 2010 10:31 pm | by EurekAlert | News | Comments

(UT Southwestern Medical Center) UT Southwestern Medical Center researchers have identified unique metabolic properties that allow a specific type of stem cell in the body to survive and replicate in low-oxygen environments.

Scientists discover the mechanisms and function of a type of mysterious immune cell

September 2, 2010 1:32 pm | by EurekAlert | News | Comments

(Scripps Research Institute) In two closely related studies, two teams of Scripps Research Institute scientists have discovered the underlying mechanisms that activate a type of immune cell in the skin and other organs. The findings may lead to the development of new therapies to treat...

Lung cancer survival rates improved through use of individualized chemotherapy

August 31, 2010 9:32 pm | by EurekAlert | News | Comments

(International Association for the Study of Lung Cancer) Chemotherapy is the best broad defense against cancer recurrence after surgical resection. However, it is difficult to predict which patients will benefit from which regimen of anticancer drugs, if at all. Building on existing...

Tumor budding identified as predictor for unfavorable outcome in lung cancer

August 31, 2010 9:32 pm | by EurekAlert | News | Comments

(International Association for the Study of Lung Cancer) Lung cancer is the leading cause of cancer deaths worldwide, and the prognosis is generally poor, even if surgery is successful. Furthermore, the incidence of one type of lung cancer, adenocarcinoma, has been increasing in recent years.

Randomized Controlled Trial Finds Masimo PVI Improves Fluid Management During Surgery

August 31, 2010 8:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., Aug. 31 /- Masimo (Nasdaq: MASI ) announced today that a new randomized controlled trial published in Anesthesia & Analgesia shows that clinicians using Masimo Pleth Variability Index (PVI®) significantly improved fluid management and reduced lactate levels in...

Pre and Post-Operative Use of Caldolor® (Ibuprofen) Injection Significantly Reduces Pain and Opioid Use in Newly Published Study

August 30, 2010 10:33 am | by Bio-Medicine.Org | News | Comments

NASHVILLE, Tenn., Aug. 30 /- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced the publication of new data supporting the safety and efficacy of Caldolor® ( ibuprofen ) Injection in pre and post-operative orthopedic surgery patients. The study, which was published in the...

Bend Research Receives Patent for Preparing Spray-Dried Drug Dispersions Using Pressure Nozzles

August 30, 2010 5:35 am | by Bio-Medicine.Org | News | Comments

BEND, Ore., Aug. 30 /- Bend Research Inc. ( www.bendres.com ), a leading independent drug-formulation development and manufacturing company, announced today that it has received a new U.S. patent covering a process for making spray-dried solid amorphous dispersions of drugs using pressure...

Covidien Completes Sale of Sleep Therapy Product Line

August 30, 2010 3:32 am | by Covidien | News | Comments

DUBLIN, Aug 30, 2010 (BUSINESS WIRE) --Covidien (NYSE: COV), a leading global provider of healthcare products, today announced that it has completed the previously announced sale of its Sleep Therapy continuous positive airway pressure (CPAP) and Bi-level products to PH Invest, a...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading